Grantham, Mayo, Van Otterloo & Co (GMO)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $690M | Buy |
749,815
+10,541
| +1% | +$10.7M | 1.76% | 19 |
|
|
2025
Q4 | $794M | Buy |
739,274
+38,666
| +6% | +$37M | 2.03% | 18 |
|
|
2025
Q3 | $535M | Buy |
700,608
+226,586
| +48% | +$169M | 1.51% | 20 |
|
|
2025
Q2 | $370M | Sell |
474,022
-9,778
| -2% | -$7.6M | 1.11% | 29 |
|
|
2025
Q1 | $400M | Buy |
483,800
+48,568
| +11% | +$40.4M | 1.26% | 27 |
|
|
2024
Q4 | $336M | Buy |
435,232
+6,368
| +1% | +$5.27M | 1.09% | 29 |
|
|
2024
Q3 | $380M | Sell |
428,864
-41,625
| -9% | -$37.4M | 1.19% | 26 |
|
|
2024
Q2 | $426M | Sell |
470,489
-213,297
| -31% | -$171M | 1.44% | 24 |
|
|
2024
Q1 | $532M | Sell |
683,786
-6,077
| -0.9% | -$4.32M | 1.93% | 18 |
|
|
2023
Q4 | $402M | Buy |
689,863
+30,370
| +5% | +$17.7M | 1.77% | 18 |
|
|
2023
Q3 | $354M | Sell |
659,493
-156,780
| -19% | -$80.8M | 1.67% | 17 |
|
|
2023
Q2 | $383M | Buy |
816,273
+28,426
| +4% | +$11.9M | 1.77% | 14 |
|
|
2023
Q1 | $271M | Buy |
787,847
+10,877
| +1% | +$3.67M | 1.38% | 19 |
|
|
2022
Q4 | $284M | Sell |
776,970
-9,871
| -1% | -$3.5M | 1.51% | 18 |
|
|
2022
Q3 | $254M | Sell |
786,841
-3,068
| -0.4% | -$972K | 1.47% | 16 |
|
|
2022
Q2 | $256M | Sell |
789,909
-136,417
| -15% | -$40.9M | 1.39% | 18 |
|
|
2022
Q1 | $265M | Sell |
926,326
-64,469
| -7% | -$16.6M | 1.28% | 20 |
|
|
2021
Q4 | $274M | Sell |
990,795
-13,334
| -1% | -$3.38M | 1.31% | 20 |
|
|
2021
Q3 | $232M | Buy |
1,004,129
+14,707
| +1% | +$3.63M | 1.15% | 22 |
|
|
2021
Q2 | $227M | Sell |
989,422
-186,299
| -16% | -$37.4M | 1.13% | 22 |
|
|
2021
Q1 | $220M | Buy |
1,175,721
+23,403
| +2% | +$4.58M | 1.2% | 23 |
|
|
2020
Q4 | $195M | Sell |
1,152,318
-207,505
| -15% | -$31M | 1.2% | 25 |
|
|
2020
Q3 | $201M | Buy |
1,359,823
+32,382
| +2% | +$5.01M | 1.43% | 24 |
|
|
2020
Q2 | $218M | Sell |
1,327,441
-4,947
| -0.4% | -$759K | 1.62% | 21 |
|
|
2020
Q1 | $185M | Sell |
1,332,388
-450,536
| -25% | -$61.9M | 1.54% | 22 |
|
|
2019
Q4 | $234M | Buy |
1,782,924
+2,004
| +0.1% | +$232K | 1.57% | 19 |
|
|
2019
Q3 | $199M | Buy |
1,780,920
+189,524
| +12% | +$21.1M | 1.38% | 24 |
|
|
2019
Q2 | $176M | Buy |
1,591,396
+1,563,537
| +5,612% | +$184M | 1.24% | 25 |
|
|
2019
Q1 | $3.62M | Sell |
27,859
-282,200
| -91% | -$34.3M | 0.03% | 329 |
|
|
2018
Q4 | $35.9M | Sell |
310,059
-63,400
| -17% | -$7.08M | 0.29% | 63 |
|
|
2018
Q3 | $40.1M | Sell |
373,459
-50,100
| -12% | -$5.01M | 0.27% | 70 |
|
|
2018
Q2 | $36.1M | Sell |
423,559
-905,790
| -68% | -$74.4M | 0.26% | 60 |
|
|
2018
Q1 | $103M | Buy |
1,329,349
+348,500
| +36% | +$28.1M | 0.63% | 44 |
|
|
2017
Q4 | $82.8M | Buy |
980,849
+178,800
| +22% | +$15.2M | 0.49% | 50 |
|
|
2017
Q3 | $68.6M | Sell |
802,049
-65,224
| -8% | -$5.35M | 0.4% | 58 |
|
|
2017
Q2 | $71.4M | Buy |
867,273
+29,054
| +3% | +$2.37M | 0.39% | 61 |
|
|
2017
Q1 | $70.5M | Sell |
838,219
-246,892
| -23% | -$19.8M | 0.4% | 65 |
|
|
2016
Q4 | $79.8M | Buy |
1,085,111
+37,801
| +4% | +$2.82M | 0.43% | 61 |
|
|
2016
Q3 | $84.1M | Buy |
1,047,310
+62,800
| +6% | +$5.03M | 0.4% | 61 |
|
|
2016
Q2 | $77.5M | Sell |
984,510
-395,783
| -29% | -$29.8M | 0.32% | 75 |
|
|
2016
Q1 | $99.4M | Sell |
1,380,293
-52,400
| -4% | -$3.96M | 0.37% | 60 |
|
|
2015
Q4 | $121M | Sell |
1,432,693
-88,682
| -6% | -$7.36M | 0.43% | 58 |
|
|
2015
Q3 | $127M | Buy |
1,521,375
+58,151
| +4% | +$4.91M | 0.44% | 50 |
|
|
2015
Q2 | $122M | Buy |
1,463,224
+1,171,568
| +402% | +$89.3M | 0.39% | 57 |
|
|
2015
Q1 | $21.2M | Sell |
291,656
-692,859
| -70% | -$49.3M | 0.06% | 134 |
|
|
2014
Q4 | $67.9M | Sell |
984,515
-1,926,338
| -66% | -$130M | 0.18% | 86 |
|
|
2014
Q3 | $189M | Sell |
2,910,853
-1,172,500
| -29% | -$74.2M | 0.5% | 43 |
|
|
2014
Q2 | $254M | Sell |
4,083,353
-1,027,371
| -20% | -$61.3M | 0.69% | 37 |
|
|
2014
Q1 | $301M | Sell |
5,110,724
-1,192,120
| -19% | -$66.5M | 0.78% | 31 |
|
|
2013
Q4 | $321M | Sell |
6,302,844
-709,976
| -10% | -$35.6M | 0.78% | 29 |
|
|
2013
Q3 | $353M | Buy |
7,012,820
+758,468
| +12% | +$39.7M | 0.93% | 27 |
|
|
2013
Q2 | $307M | Buy |
+6,254,352
| New | +$340M | 0.8% | 29 |
|
Other funds holding LLY
VCM
VPM
Grantham, Mayo, Van Otterloo & Co (GMO)'s LLY Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Eli Lilly (LLY) stake by 1.4% in Q1 2026, buying an estimated $10.7M and bringing the position to 749,815 shares worth $690M. The position accounts for 1.76% of the portfolio, ranked #19.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $794M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 749,815 shares of Eli Lilly worth $690M as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 10,541 Eli Lilly shares in Q1 2026, an estimated $10.7M.
- Eli Lilly made up 1.76% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #19 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Eli Lilly position peaked at $794M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.